Список проголосовавших за комментарий " On The Wires<ul><li>IBM Watson Health (<strong>IBM</strong>) has signed a research initiative with the FDA aimed at defining a secure, efficient and scalable exchange of health data using blockchain technology. IBM and the FDA will explore the exchange of owner mediated data from several sources, such as Electronic Medical Records, clinical trials, genomic data, and health data from mobile devices, wearables and the «Internet of Things.» The initial focus will be on oncology-related data.</li><li>Bird Rock Bio announced that it has received approval for the initiation of a two-part Phase 1 clinical trial for namacizumab, a novel therapeutic antibody to the cannabinoid 1 receptor. In addition, Bird Rock Bio has entered into an agreement with GE Healthcare (<strong>GE</strong>) for process development, formulation, and manufacture of namacizumab in preparation for Phase 2 studies. Furthermore, the Phase 1 trial, process development, and Phase 2 preparation will be funded under a collaboration and option agreement with Janssen Pharmaceuticals (<strong>JNJ</strong>). </li><li>The J. M. Smucker Company (<strong>SJM</strong>) announced an increase in the list price for the majority of its packaged coffee products sold in the United States, primarily consisting of items sold under the Folgers, Dunkin' Donuts, and Café Bustelo brand names. Prices increased an average of six percent on impacted items in response to sustained increases in green coffee costs. The Company's K-Cup pods were excluded from the price increase. </li><li>Subsidiaries of Imperial Brands PLC (<strong>IMBBY</strong>) and China Tobacco have established a dynamic long-term Joint Venture business which will look to develop a variety of growth opportunities in China and international markets. Global Horizon Ventures Limited is initially focused on: leveraging the expertise of China's largest tobacco company, Yunnan Tobacco, to drive the sustainable growth of Imperial's Growth Brands West and Davidoff in China; and maximising the potential of two Yunnan brands, Jadé and Horizon, in markets outside of China.</li><li>At its board meeting, SNCF selected the Alstom (<strong>ALSMY</strong>)-Bombardier (<strong>BDBRF</strong>) consortium to renew the trains on lines D and E of the Île-de-France network. This contract for 255 trains (130 for the RER D and 125 for the RER E), worth an estimated 3.75 billion euros, is the largest contract ever financed by STIF.</li></ul>"